Ledger.Open graph →
SEC Form D · filed February 8, 2019

Linnaeus Therapeutics, Inc

Offering
—
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HADDONFIELD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Nicholas T. Iatropoulos · Haddonfield, NJDirectorPatrick T. Mooney · Haddonfield, NJExec · DirectorMichael D. Poisel · Haddonfield, NJDirectorChristopher D. Natale · Haddonfield, NJExecWayne D. Linsley · Englewood Cliffs, NJDirectorGrace S. Lee · Grand Cayman, Cayman IslandsExecAlta Fox Connor GenPar, LP · FORT WORTH, TXDirectorShaival Shah · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗